Labcorp Holdings ( (LH) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Labcorp shares are sliding today after a new report from the Centers for Medicare & Medicaid Services revealed that Medicare has been overpaying for lab tests versus private insurers and now plans to cut reimbursement rates by as much as 15% starting in 2027. Investors worry this will squeeze profit margins across the diagnostics industry, driving a broad sell-off in laboratory stocks rather than a Labcorp-specific issue.
Despite the hit from looming Medicare cuts, Labcorp’s long-term story still has support from its expanding biopharma lab services backlog and recent gains in revenue and operating margins, which give the company more room to invest in new tests and technology. However, heavy reliance on Medicare pricing and still-below-peak margins mean future earnings could feel ongoing pressure, especially if debt limits Labcorp’s flexibility to respond to reimbursement and cost challenges.
More about Labcorp Holdings
YTD Price Performance: 24.31%
Average Trading Volume: 735,861
Technical Sentiment Signal: Strong Buy
Current Market Cap: $25.11B
For further insights into LH stock on
TipRanks’ Stock Analysis page.
See more of today’s
top stock gainers and losers.